UBS analyst Kevin Caliendo raised the firm’s price target on Labcorp (LH) to $305 from $282 and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp price target raised to $310 from $290 at Truist
- Labcorp price target raised to $302 from $290 at Baird
- Labcorp price target raised to $306 from $283 at Morgan Stanley
- Positive Outlook for Labcorp Holdings: Buy Rating Justified by Strong Future Prospects and Strategic Growth Initiatives
- Labcorp Reports Strong Q2 2025 Results, Raises Guidance